ACADIA Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 8, 2012
09:00 EDT 1 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company
focused on innovative treatments that address unmet medical needs in
neurological and related central nervous system disorders, today
announced that it will ...
Other Sources for this Article
ACADIA Pharmaceuticals Inc.
Thomas H. Aasen, Executive Vice
President,
Chief Financial Officer and Chief Business Officer
(858)
558-2871
More From BioPortfolio on "ACADIA Pharmaceuticals to Announce Second Quarter 2012 Financial Results on August 8, 2012"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
